← Leaderboards
Geoffrey G Murphy
University Of California Los Angeles
$8,439,207
Attributed
$14,003,553
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,003,553 · 8
By mechanism
R01$9,804,923 · 4
U01$3,481,094 · 1
R21$646,604 · 2
F32$70,932 · 1
Top collaborators
- Brian M Bennett5 shared
- Bruce A. Berkowitz5 shared
- Daniel A Lawrence5 shared
- Olivier Thibault5 shared
- Eva L Feldman4 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Marjorie Louise Kagawa-Singer$2,279,624
- Peter J Tontonoz$38,870,418
- Theresa M. Harrison$905,076
- Gary William Small$17,082,455
- Tina Bilousova$433,125
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposMemoryLearningS DiseaseMouse ModelHippocampus (Brain)DementiaCognitionNeuronsAgingImpaired CognitionPlayBaseCalciumImpairmentAnimalsPathologyTissuesTransgenic OrganismsCognitive DeficitsAffectFutureS Disease ModelTranslating
Grant awards (31)
The Role of PAI-1 in Cerebral Microvascular Dysfunction and the Development of Alzheimerâs Disease Neuropathology$674,476
R01 · FY2025 · AG
The Role of PAI-1 in Cerebral Microvascular Dysfunction and the Development of Alzheimerâs Disease Neuropathology$691,234
R01 · FY2024 · AG
The Role of PAI-1 in Cerebral Microvascular Dysfunction and the Development of Alzheimerâs Disease Neuropathology$691,234
R01 · FY2023 · AG
The Role of PAI-1 in Cerebral Microvascular Dysfunction and the Development of Alzheimerâs Disease Neuropathology$670,156
R01 · FY2022 · AG
The Role of PAI-1 in Cerebral Microvascular Dysfunction and the Development of Alzheimerâs Disease Neuropathology$670,156
R01 · FY2021 · AG
Novel Imaging Biomarker for Treating Spatial Memory Loss in Prodromal Alzheimer's Disease Models$558,744
R01 · FY2021 · AG
Neural Stem Cell Transplantation: A Novel Cellular Therapy for Alzheimer's Disease$1,371,564
U01 · FY2020 · AG
Novel Imaging Biomarker for Treating Spatial Memory Loss in Prodromal Alzheimer's Disease Models$558,744
R01 · FY2020 · AG
Testing the Calcium Hypothesis of Age-related Cognitive Decline$405,370
R01 · FY2020 · AG · contact PI
Neural Stem Cell Transplantation: A Novel Cellular Therapy for Alzheimer's Disease$1,032,520
U01 · FY2019 · AG
Novel Imaging Biomarker for Treating Spatial Memory Loss in Prodromal Alzheimer's Disease Models$558,744
R01 · FY2019 · AG
Testing the Calcium Hypothesis of Age-related Cognitive Decline$405,370
R01 · FY2019 · AG · contact PI
Neural Stem Cell Transplantation: A Novel Cellular Therapy for Alzheimer's Disease$390,000
U01 · FY2019 · AG
Neural Stem Cell Transplantation: A Novel Cellular Therapy for Alzheimer's Disease$687,010
U01 · FY2018 · AG
Novel Imaging Biomarker for Treating Spatial Memory Loss in Prodromal Alzheimer's Disease Models$558,144
R01 · FY2018 · AG
Testing the Calcium Hypothesis of Age-related Cognitive Decline$405,370
R01 · FY2018 · AG · contact PI
Novel Imaging Biomarker for Treating Spatial Memory Loss in Prodromal Alzheimer's Disease Models$599,186
R01 · FY2017 · AG
Testing the Calcium Hypothesis of Age-related Cognitive Decline$413,120
R01 · FY2017 · AG · contact PI
Testing the Calcium Hypothesis of Age-related Cognitive Decline$50,000
R01 · FY2017 · AG · contact PI
Testing the Calcium Hypothesis of Age-related Cognitive Decline$420,870
R01 · FY2016 · AG · contact PI
L-type Calcium Channels, Neuronal Excitability & Cognition in Aged Mice$287,783
R01 · FY2012 · AG · contact PI
L-type Calcium Channels, Neuronal Excitability & Cognition in Aged Mice$287,783
R01 · FY2011 · AG · contact PI
L-type Calcium Channels, Neuronal Excitability & Cognition in Aged Mice$299,400
R01 · FY2010 · AG · contact PI
L-type Calcium Channels, Neuronal Excitability & Cognition in Aged Mice$299,743
R01 · FY2009 · AG · contact PI
L-type Calcium Channels, Neuronal Excitability & Cognition in Aged Mice$299,296
R01 · FY2008 · AG · contact PI
The role of Kv?2 deletion in the neurological phenotype of 1p36 deletion syndrome$153,337
R21 · FY2008 · NS · contact PI
The role of Kv?2 deletion in the neurological phenotype of 1p36 deletion syndrome$173,074
R21 · FY2007 · NS · contact PI
Age-related cognitive decline: a transgenic approach$149,267
R21 · FY2006 · AG · contact PI
Age-related cognitive decline: a transgenic approach$170,926
R21 · FY2005 · AG
AGE RELATED MEMORY CHANGES IN KVB11 DEFICIENT MICE$38,516
F32 · FY2001 · AG
AGE RELATED MEMORY CHANGES IN KVB11 DEFICIENT MICE$32,416
F32 · FY2000 · AG